Arax Advisory Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.6K | Buy |
190
+42
| +28% | +$12.1K | ﹤0.01% | 1192 |
|
|
2025
Q1 | $45.6K | Sell |
148
-284
| -66% | -$87.5K | ﹤0.01% | 980 |
|
|
2024
Q4 | $152K | Sell |
432
-32
| -7% | -$11.3K | 0.01% | 555 |
|
|
2024
Q3 | $166K | Buy |
464
+4
| +0.9% | +$1.43K | 0.01% | 383 |
|
|
2024
Q2 | $147K | Buy |
460
+437
| +1,900% | +$139K | 0.01% | 393 |
|
|
2024
Q1 | $5.28K | Hold |
23
| – | – | ﹤0.01% | 888 |
|
|
2023
Q4 | $5.06K | Buy |
23
+3
| +15% | +$660 | ﹤0.01% | 884 |
|
|
2023
Q3 | $4.52K | Sell |
20
-5
| -20% | -$1.13K | ﹤0.01% | 897 |
|
|
2023
Q2 | $5.52K | Hold |
25
| – | – | ﹤0.01% | 846 |
|
|
2023
Q1 | $5.6K | Hold |
25
| – | – | ﹤0.01% | 815 |
|
|
2022
Q4 | $6.95K | Hold |
25
| – | – | ﹤0.01% | 708 |
|
|
2022
Q3 | $5K | Buy |
25
+5
| +25% | +$1K | ﹤0.01% | 827 |
|
|
2022
Q2 | $5K | Buy |
+20
| New | +$5K | ﹤0.01% | 802 |
|